Yuki Naitou - Concepedia

Author

Yuki Naitou

Also Known As

Yuki Naitou

Publications

132

Citations

H-Index

Concepts

All Affiliations

Yuki Naitou is an author at Astellas Pharma (Japan) specializing in pharmacology, medicine, and drug discovery.

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	117
2	Social Sciences	1	1	20
3	Biochemistry	1	1	52
4	Endocrinology	1	1	20
5	Neuroscience	1	1	20

Yuki Naitou

Publications

131

Citations

H-Index

Page 1

	Year	Citations
Pharmacological profile of YM348, a novel, potent and orally active 5-HT2C receptor agonist Yasuharu Kimura, Ken-ichi Hatanaka, Yuki Naitou, European Journal of Pharmacology BiochemistryFunctional SelectivityMedicineMechanism Of ActionPharmacotherapy	2003	52
Synthesis and structure–activity relationships of a series of substituted 2-(1H-furo[2,3-g]indazol-1-yl)ethylamine derivatives as 5-HT2C receptor agonists Itsuro Shimada, Kyoichi Maeno, Kenichi Kazuta, Bioorganic & Medicinal Chemistry Molecular PharmacologyMedicine5-Ht2c Receptor AgonistsMechanism Of ActionEthylamine Derivatives	2007	35
5-HT2C receptor activation is a common mechanism on proerectile effects of apomorphine, oxytocin and melanotan-II in rats Yasuharu Kimura, Yuki Naitou, Fumikazu Wanibuchi, European Journal of Pharmacology Proerectile EffectsNeurophysiologyCommon MechanismMedicinePhysiology	2008	20
Characterization of Intracavernous Pressure Increase Induced by Ym348, a Novel 5-HT <sub>2C</sub> Receptor Agonist, in Anesthetized Rats Yasuharu Kimura, Yuki Naitou, Fumikazu Wanibuchi, The Journal of Urology	2006	14
Synthesis and structure–activity relationships of a series of benzazepine derivatives as 5-HT2C receptor agonists Itsuro Shimada, Kyoichi Maeno, Yutaka Kondoh, Bioorganic & Medicinal Chemistry Molecular PharmacologyMedicine5-Ht2c Receptor AgonistsPharmacological AgentBenzazepine Derivatives	2007	10

Page 1